Not applicableStudy completedNCT01524445What this trial is testingRetrospective Survey of Re-treatment With BortezomibWho this might be right forHematological CancerMultiple Myeloma Janssen Pharmaceutica N.V., Belgium 35
Not applicableNot Yet RecruitingNCT07480967What this trial is testingComparison of Platelet-Rich Plasma and Prolotherapy for Plantar FasciitisWho this might be right forPlanter Fasciitis Bangladesh Medical University 68
Early research (Phase 1)Ended earlyNCT06597656What this trial is testingA Gene Transfer Therapy to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) Following Therapeutic Plasma Exchange (Plasmapheresis) in Participants With Duchenne Muscular Dystrophy (DMD) and Pre-existing Antibodies to AAVrh74Who this might be right forDuchenne Muscular Dystrophy Sarepta Therapeutics, Inc. 3
Testing effectiveness (Phase 2)Study completedNCT01720875What this trial is testingVorinostat, Bortezomib and Dexamethasone in Multiple Myeloma (MUKFour)Who this might be right forMultiple Myeloma University of Leeds 16
Not applicableNo Longer AvailableNCT02368301What this trial is testingExpanded Access Treatment Protocol CA204-143Who this might be right forMultiple Myeloma Bristol-Myers Squibb
Large-scale testing (Phase 3)Study completedNCT02316353What this trial is testingEvaluate the Long-term Clinical Safety and Efficacy of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary AngioedemaWho this might be right forHereditary Angioedema Types I and II CSL Behring 126
Large-scale testing (Phase 3)UnknownNCT01532856What this trial is testingIberoamerican Protocol With Thalidomide in Patients With Symptomatic Newly Diagnosed Multiple Myeloma Over 65 YearsWho this might be right forMultiple Myeloma Grupo de Estudos Multicentricos em Onco-Hematologia 64
Testing effectiveness (Phase 2)Ended earlyNCT04432272What this trial is testingANTIBODY-LEVEL BASED ANALYSIS OF COVID-19 CONVALESCENT SERUM (ABACCuS)Who this might be right forCOVID-19Severe Acute Respiratory Syndrome (SARS)Coronavirus Infections Corewell Health East 71
Large-scale testing (Phase 3)Study completedNCT00430365What this trial is testingMaintenance Therapy Using Lenalidomide in MyelomaWho this might be right forMyeloma University Hospital, Toulouse 614
Testing effectiveness (Phase 2)Study completedNCT00448357What this trial is testingAllogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based RegimenWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+2 more UNC Lineberger Comprehensive Cancer Center 54
Post-approval studies (Phase 4)Study completedNCT03122119What this trial is testingEffectiveness of Ultrasound Guided Platelet Rich Plasma Injections in the Sacroiliac JointWho this might be right forChronic Low Back PainSacroiliitisSacroiliac; Backache+5 more Star Spine and Sport 51
Testing effectiveness (Phase 2)Active Not RecruitingNCT06390865What this trial is testingTesting MLN0128 (TAK-228) as Potentially Targeted Treatment in Cancers With TSC1 or TSC2 Genetic Changes (MATCH - Subprotocol M)Who this might be right forAdvanced LymphomaAdvanced Malignant Solid NeoplasmRefractory Lymphoma+2 more National Cancer Institute (NCI) 49
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439136What this trial is testingTesting Afatinib as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes (MATCH-Subprotocol B)Who this might be right forAdvanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more National Cancer Institute (NCI) 40
Not applicableStudy completedNCT04151615What this trial is testingVMP Regimen - Safety, Efficacy, and Optimal Dose Finding Study for Patients With Multiple MyelomaWho this might be right forMultiple Myeloma Boryung Pharmaceutical Co., Ltd 203
Testing effectiveness (Phase 2)Study completedNCT00051116What this trial is testingA Phase II Study of Continuous Versus Syncopated Dosing of CC-5013 for the Treatment of Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Celgene Corporation 100
Not applicableStudy completedNCT03389347What this trial is testingHigh Throughput Drug Sensitivity and Genomics Data in Developing Individualized Treatment in Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell LeukemiaWho this might be right forPlasma Cell LeukemiaRecurrent Multiple MyelomaRefractory Multiple Myeloma University of Washington 40
Testing effectiveness (Phase 2)Looking for participantsNCT06644443What this trial is testingBCMA-GPRC5D CAR-T Therapy in Relapsed or Refractory Multiple MyelomaWho this might be right forMultiple Myeloma in Relapse Shenzhen University General Hospital 10
Not applicableLooking for participantsNCT06133426What this trial is testingEvaluation of the Role of Connected Scales in the Therapeutic Care of Hematology PatientsWho this might be right forLymphoma, Non-HodgkinMyeloma Multiple Assistance Publique - Hôpitaux de Paris 30
Early research (Phase 1)Study completedNCT02159326What this trial is testingMicrogynon Riociguat Drug Interaction Study in Healthy Postmenopausal WomenWho this might be right forDrug Interactions Bayer 31
Not applicableStudy completedNCT02331914What this trial is testingGIST: Assessment of Tumor Mutations and TKI Plasma ExposureWho this might be right forGastro-intestinal Stromal Tumor University Medical Center Groningen 740